Discover how High-Intensity Focused Ultrasound (HIFU) treatment is revolutionizing care for prostate cancer and tumours with ...

After skin cancer, prostate cancer is the most commonly diagnosed cancer among men in the United States. In fact, one in eight men will be diagnosed with prostate cancer during their lifetime, ...

Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3 clinical trial has ...

But a practice called integrative medicine, which combines conventional cancer therapies with complementary and holistic treatments, is increasingly being used to manage the disease. While ...

One in eight men in the United States will develop prostate cancer as they get older. It’s the most common cancer in men in this country besides skin cancer. Worldwide, it is second only to lung ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

• Applications of germline genetic testing, tumor genomics, and other biomarkers are now routinely used in risk assessment, determination of treatment course, prognosis, and monitoring. • Imaging ...

Men diagnosed with localized prostate cancer who want to avoid immediate surgery or radiation can safely choose to actively monitor the disease as a treatment method, according to a study released ...

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the best to prescribe upfront—and to which patients. Over the past 14 years, ...

Cancer of the prostate has become the leading cause of cancer diagnoses among males in the United Kingdom. Its treatment, ...